Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-06-21
2005-06-21
Tate, Christopher (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S300000, C530S350000
Reexamination Certificate
active
06908900
ABSTRACT:
Disclosed herein are novel pharmaceutical agents and compositions, as well as novel methods, to enhance the absorption of polypeptide drug substances that normally display little if any absorbability if administered orally. Also disclosed are novel compositions and methods to significantly enhance the bioavailability and pharmacological efficacy of polypeptide drug substances whether administered orally or parenterally.
REFERENCES:
patent: 4239754 (1980-12-01), Sache et al.
patent: 4339534 (1982-07-01), Johansen et al.
patent: 4396606 (1983-08-01), Goldstein
patent: 4694006 (1987-09-01), Bundgaard et al.
patent: 4925673 (1990-05-01), Steiner et al.
patent: 5212158 (1993-05-01), Vandai
patent: 6136952 (2000-10-01), Li et al.
patent: 2002/0090603 (2002-07-01), Lipton et al.
patent: WO 98/11126 (1998-03-01), None
Fukushima, K., Hypoglycemic Effect and Enhanced Gastrointestinal Absorption of Insulin Using New Cinnamoyl-phenylalanine Derivatives, Hokkaido Journal of Medical Science, vol. 71, No. 6, 1996, pp. 727-743.
Vergnolle, N, et al., Proteinase-Activated Receptor 2 (PAR2)-Activating Peptides: Identification of a Receptor Distinct From PAR2That Regulates Intestinal, Transport, Proceedings of the National Academy of Sciences of USA, National Academy of Science, vol. 95, (Jun. 1998), pp. 7766-7771.
Langguth, P., et al., The Challenge of Proteolytic Enzymes in Intestinal Peptide Delivery, Journal of Controlled Release, Elsevier Science Publishers B.V. Amsterdam, NL, vol. 46, No. 1, May 1997, pp. 39-57.
Egleton, R. D., et al., Improved Bioavailability to the Brain of Glycosylated Met-Enkephalin Analogs, Brain Research, vol. 881, No. 1, 2000, pp. 37-46.
Pauletti, G. M., et al., Improvement of Oral Peptide Bioavailability: Peptidomimetics and Prodrug Strategies, Advanced Drug Delivery Review, vol. 27, No. 2-3, 1997, pp. 235-256.
Ahlers, et al., Enhanced Immunogenicity of HIV-1 Vaccine Construct By Modification of the Native Peptide Sequence, Proc. Natl. Acad. Sci. USA, vol. 94, pp. 10856-10861, Sep. 1997.
Greenstein, et al., A Universal T Cell Epitope-Containing Peptide From Hepatitis B Surface Antigen Can Enhance Antibody Specific For HIV gp120, Journal of Immunology, vol. 148, pp. 3970-3977, No. 12, Jun. 1992.
Belyakov, et al., The Importance of Local Mucosal HIV-Specific CD8* Cytotoxic T Lymphocytes For Resistance to Mucosal Viral Transmission in Mice and Enhancement of Resistance by Local Administration of IL-12, The Journal of Clinical Investigation, vol. 102(12); pp. 2072-2081, Dec. 1998.
Belyakov, et al., Mucosal Immunization With HIV-1 Peptide Vaccine Induces Mucosal and Systemic Cytotoxic T Lymphocytes and Protective Immunity in Mice Against Intrarectal Recombinant HIV-Vaccinia Challenge, Proc. Natl. Acad. Sci. USA, vol. 95, pp. 1709-1714, Feb. 1998.
Patel, et al., Oral Administration of Insulin By Encapsulation Within Liposomes, North-Holland Publishing Company, vol. 62, No. 1, pp. 60-63, Feb. 1976.
Hashimoto, et al., ACTH Release in Pituitary Cell Cultures, Effect of Neurogenic Peptides and Neurotransmitter Substances Corticotropin Releasing Factor (CRF), Endocrinol. Japan, vol. 26 (1), pp. 103-109, Feb. 1979.
McCarter & English LLP
Tate Christopher
Teller Roy
Zimmer & Associates AG
LandOfFree
COMPOSITIONS AND METHODS FOR ENHANCED PHARMACOLOGICAL... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with COMPOSITIONS AND METHODS FOR ENHANCED PHARMACOLOGICAL..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and COMPOSITIONS AND METHODS FOR ENHANCED PHARMACOLOGICAL... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3521399